.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
QuintilesIMS
Dow
Deloitte
US Department of Justice
Covington
Medtronic
Mallinckrodt
Cipla
Federal Trade Commission

Generated: September 25, 2017

DrugPatentWatch Database Preview

ANTHELIOS 20 Drug Profile

« Back to Dashboard

What is the patent landscape for Anthelios 20, and when can generic versions of Anthelios 20 launch?

Anthelios 20 is a drug marketed by Loreal Usa and is included in one NDA.

The generic ingredient in ANTHELIOS 20 is avobenzone; ecamsule; octocrylene; titanium dioxide. There are two drug master file entries for this compound. Additional details are available on the avobenzone; ecamsule; octocrylene; titanium dioxide profile page.

Summary for Tradename: ANTHELIOS 20

Patents:0
Applicants:1
NDAs:1
Clinical Trials: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ANTHELIOS 20 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Loreal Usa
ANTHELIOS 20
avobenzone; ecamsule; octocrylene; titanium dioxide
CREAM;TOPICAL021471-001Oct 5, 2006OTCYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
QuintilesIMS
Moodys
Accenture
McKinsey
UBS
Farmers Insurance
Medtronic
Teva
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot